1. Home
  2. INDP vs ISPO Comparison

INDP vs ISPO Comparison

Compare INDP & ISPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • ISPO
  • Stock Information
  • Founded
  • INDP 2000
  • ISPO 2010
  • Country
  • INDP United States
  • ISPO United States
  • Employees
  • INDP N/A
  • ISPO N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • ISPO Blank Checks
  • Sector
  • INDP Health Care
  • ISPO Finance
  • Exchange
  • INDP Nasdaq
  • ISPO Nasdaq
  • Market Cap
  • INDP 5.0M
  • ISPO 49.5M
  • IPO Year
  • INDP N/A
  • ISPO N/A
  • Fundamental
  • Price
  • INDP $11.16
  • ISPO $3.56
  • Analyst Decision
  • INDP Strong Buy
  • ISPO
  • Analyst Count
  • INDP 2
  • ISPO 0
  • Target Price
  • INDP $8.50
  • ISPO N/A
  • AVG Volume (30 Days)
  • INDP 689.4K
  • ISPO 29.4K
  • Earning Date
  • INDP 08-11-2025
  • ISPO 08-12-2025
  • Dividend Yield
  • INDP N/A
  • ISPO N/A
  • EPS Growth
  • INDP N/A
  • ISPO N/A
  • EPS
  • INDP N/A
  • ISPO N/A
  • Revenue
  • INDP N/A
  • ISPO $265,499,000.00
  • Revenue This Year
  • INDP N/A
  • ISPO N/A
  • Revenue Next Year
  • INDP N/A
  • ISPO $148.67
  • P/E Ratio
  • INDP N/A
  • ISPO N/A
  • Revenue Growth
  • INDP N/A
  • ISPO N/A
  • 52 Week Low
  • INDP $7.56
  • ISPO $3.11
  • 52 Week High
  • INDP $66.64
  • ISPO $9.31
  • Technical
  • Relative Strength Index (RSI)
  • INDP 49.29
  • ISPO 44.25
  • Support Level
  • INDP $8.71
  • ISPO $3.32
  • Resistance Level
  • INDP $13.44
  • ISPO $4.90
  • Average True Range (ATR)
  • INDP 2.05
  • ISPO 0.44
  • MACD
  • INDP 0.25
  • ISPO -0.07
  • Stochastic Oscillator
  • INDP 23.81
  • ISPO 15.19

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About ISPO Inspirato Incorporated

Inspirato Inc is a private, luxury hospitality club that provides its members with access to an exclusive portfolio of high-end vacation homes, luxury hotels, and curated travel experiences worldwide. The club offers personalized service, dedicated trip planning, and seamless access to exceptional properties through its innovative model designed to ensure the service, certainty and value that discerning customers demand. The Inspirato portfolio of curated luxury vacation options includes approximately 350 private luxury vacation homes and accommodations at over 220 luxury hotel and resort partners in over 180 destinations around the world.

Share on Social Networks: